Progesterone modulation of diazepam withdrawal syndrome in mice

Pharmacology and Toxicology

Volumn 79, Issue 6, 1996, Pages 331-333

  Pesce, M E ^a   Acevedo, X ^a   Pinardi, G ^a   Miranda, H F ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZEPAM; ESTRADIOL; FLUMAZENIL; PROGESTERONE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ESTRUS; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE; SUBCUTANEOUS DRUG ADMINISTRATION; WITHDRAWAL SYNDROME;

EID: 0030444976     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1996.tb00018.x     Document Type: Article

References (18)

1. Albertson, T. E., W. S. Walby & R. M. Joy: Modification of GABA-mediated inhibition by various injectable anesthetics. Anesthesiology 1992, 77, 488-499.
2. Backström, J.: Oestrogen and progesterone in relation to different activities in the central nervous system. Acta obstet. gynaecol. scand. 1977, 66, 1.
3. Biegon, A. & B. S. McEwen: Modulation by estradiol of serotonin receptors in the brain. J. Neurosci. 1982, 2, 199-205.
4. Bitran, D., R. J. Hilvers, & C. K. Kellog: Ovarian endocrine status modulates the anxiolytic potency of diazepam and the efficacy of gamma-aminobutyric acid-benzodiazepine receptor-mediated chloride ion transport. Behav. Neurosci. 1991a, 105, 653-662.
5. Bitran, D., R. H. Hilvers, & C. K. Kellog: Anxiolytic effects of 3 alpha-hydroxy-5 alpha[beta]-pregnan-20-one: endogenous metabolites of progesterone that are active at the GABAA receptor. Brain Res. 1991b, 561, 157-161.
6. Bitran, D., M. Shiekh, & M. Mc Leod: Anxiolytic effects of progesterone is mediated by the neurosteroid allopregnanolone at brain GABAA receptors. J. Neuroendocrinol. 1995, 7, 1971-1977.
7. Brot, M., G. F. Koob & K. T. Britton: Anxiolytic effects of steroid hormones during the estrous cycle. Interactions with ethanol. Recent Dev. Alcohol 1995, 12, 243-259.
8. Butcher, R. L., W. E. Collins & N. W. Fugo: plasma concentration of LH, FSH, prolactin, progesterone and estradiol-17 β throughout the 4-day estrous cycle of the rat. Endocrinology 1974, 94, 1704-1708.
9. Dawson-Basoa, M. E., & A. R. Gintzler: 17-β-estradiol and progesterone modulate an intrinsic opioid analgesic system. Brain Res. 1993, 601, 241-245.
10. A receptor complex modulation. Adv. Biochem. Psychopharmacol. 1992, 47, 133-141.
11. Heritage, A. S., W. E. Stumpf, M. Star & L. Grant: Brainstem catecholamine neurons are target sites for sex steroid hormones. Science 1980, 207, 1377-1379.
12. Hruska, R. E. & E. K. Silbergeld: Estrogen treatment enhances dopamine receptor sensitivity in the rat stratium. Eur. J. Pharmacol. 1980, 61, 397-400.
13. A receptor alone. Life Sci. 1989, 45, 1715-1719.
14. Kendall, D. A., G. M. Stancel & S. J. Enna: Imipramine: effect of ovarian steroids on modification in serotonin receptor binding. Science 1981, 211, 1183-1185.
15. Liggett, S. B. & J. R. Raymond: Pharmacology and molecular biology of adrenergic receptors. Clin. Endocrinol. Metab. 1993, 7, 279-306.
16. Pesce, M. E., X. Acevedo, G. Pinardi & H. F. Miranda: Gender differences in diazepam withdrawal syndrome in mice. Pharmacology. & Toxicology. 1994, 75, 353-355.
17. Pfaff, D. & B. S. McEwen: Action of estrogens and progestin on nerve cells. Science 1983, 219, 808-814.
18. A receptor stimulation during the oestrus cycle of the rat. Brit. J. Pharmacol. 1991, 103, 1580-1584.